banner2

Getting started
5-Bromovaleric Acid Methyl Ester

5-Bromovaleric Acid Methyl Ester - China Manufacturers, Factory, Suppliers

5-Bromovaleric Acid Methyl Ester, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

D-Glutamic Acid Dimethyl Ester Hydrochloride CAS 27025-25-8 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — D-Glutamic Acid Dimethyl Ester Hydrochloride CAS 27025-25-8 Assay ≥99.0% (Titration)
Read More

4-Formylcinnamic Acid Methyl Ester CAS 7560-50-1 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-Formylcinnamic Acid Methyl Ester CAS 7560-50-1 Purity >98.0% (GC)

Z-Asp-OMe CAS 4668-42-2 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Z-Asp-OMe CAS 4668-42-2 Z-L-Aspartic Acid α-Methyl Ester Purity >98.0% (HPLC)

Boc-Pyr-OMe CAS 108963-96-8 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Boc-Pyr-OMe CAS 108963-96-8 N-Boc-L-Pyroglutamic Acid Methyl Ester Purity >98.0% (HPLC)

Fmoc-Asp(OMe)-OH CAS 145038-53-5 Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Fmoc-Asp(OMe)-OH CAS 145038-53-5 Fmoc-L-Aspartic Acid β-Methyl Ester Purity >98.0% (HPLC)

H-Asp-OMe CAS 17812-32-7 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Asp-OMe CAS 17812-32-7 L-Aspartic Acid α-Methyl Ester Purity >98.5% (TLC)

H-Asp(OMe)-OH·HCl CAS 16856-13-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Asp(OMe)-OH·HCl CAS 16856-13-6 L-Aspartic Acid β-Methyl Ester Hydrochloride Purity >99.0% (TLC)

banner4

Top Selling Products

Related Blog
Reviews

5-Fluorouracil (5-FU) CAS 51-21-8 USP43 Standard

Fluorouracil C4H3FN2O2 130.08 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-; 5-Fluorouracil [51-21-8]; UNII: U3P01618RT. DEFINITION Fluorouracil contains NLT 98.0% and NMT 102.0% of uorouracil (C4H3FN2O2),...
Sodium Salicylate CAS 54-21-7 USP35 Standard

Sodium Salicylate C7H5NaO3 160.10 Benzoic acid, 2-hydroxy-, monosodium salt; Monosodium salicylate [54-21-7]; UNII: WIQ1H85SYP. DEFINITION Sodium Salicylate contains NLT 98.0% and NMT 102.0% of so...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.10.14 13:23:50
2022.09.30 01:37:54
2022.08.02 08:09:05
2022.07.26 06:49:11
2022.05.25 08:40:26
2022.01.22 17:58:46

related search